Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: A double-blind, placebo-controlled, randomized trial

Heart Rhythm

Volumn 9, Issue 2, 2012, Pages 172-178

  Suleiman, Mahmoud ^a   Koestler, Celeste ^b   Lerman, Amir ^b   Lopez Jimenez, Francisco ^b   Herges, Regina ^b   Hodge, David ^b   Bradley, David ^b   Cha, Yong Mei ^b   Brady, Peter A ^b   Munger, Thomas M ^b   Asirvatham, Samuel J ^b   Packer, Douglas L ^b   Friedman, Paul A ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b MAYO CLINIC   (United States)

Author keywords

Atorvastatin; Atrial fibrillation ablation; Randomized trial; Recurrence

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULMONARY VEIN ISOLATION; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; DOUBLE-BLIND METHOD; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY VEINS; PYRROLES; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME;

EID: 84856223258     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.09.016     Document Type: Article

References (26)

1. V. Fuster, L.E. Ryden, D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
2. A.J. Camm, P. Kirchhof, G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
3. H. Calkins, J. Brugada, D.L. Packer HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation Heart Rhythm 4 2007 816 861
4. J.I. Choi, H.N. Pak, J.S. Park Clinical significance of early recurrences of atrial tachycardia after atrial fibrillation ablation J Cardiovasc Electrophysiol 21 2010 1331 1337
5. M.D. O'Neill, P. Jais, M. Hocini Catheter ablation for atrial fibrillation Circulation 116 2007 1515 1523
6. T.T. Issac, H. Dokainish, N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J Am Coll Cardiol 50 2007 2021 2028
7. J. Li, J. Solus, Q. Chen Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm 7 2010 438 444
8. R.J. Aviles, D.O. Martin, C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
9. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M.A. Russo, A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
10. P. Patel, H. Dokainish, P. Tsai, N. Lakkis Update on the association of inflammation and atrial fibrillation J Cardiovasc Electrophysiol 21 2010 1064 1070
11. M.H. Shishehbor, M.L. Brennan, R.J. Aviles Statins promote potent systemic antioxidant effects through specific inflammatory pathways Circulation 108 2003 426 431
12. L. Fauchier, B. Pierre, A. de Labriolle, C. Grimard, N. Zannad, D. Babuty Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials J Am Coll Cardiol 51 2008 828 835
13. I. Savelieva, A. Kourliouros, J. Camm Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance Naunyn Schmiedebergs Arch Pharmacol 381 2010 1 13
14. G. Patti, M. Chello, D. Candura Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study Circulation 114 2006 1455 1461
15. P. Jais, M. Hocini, L.F. Hsu Technique and results of linear ablation at the mitral isthmus Circulation 110 2004 2996 3002
16. L. Gepstein, G. Hayam, S.A. Ben-Haim A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart In vitro and in vivo accuracy results Circulation 95 1997 1611 1622
17. R.S. Bubien, S.M. Knotts-Dolson, V.J. Plumb, G.N. Kay Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias Circulation 94 1996 1585 1591
18. A. Wokhlu, K.H. Monahan, D.O. Hodge Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect J Am Coll Cardiol 55 2010 2308 2316
19. C.W. Siu, C.P. Lau, H.F. Tse Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion Am J Cardiol 92 2003 1343 1345
20. H. Almroth, N. Hoglund, K. Boman Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study Eur Heart J 30 2009 827 833
21. Y.B. Song, Y.K. On, J.H. Kim The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery Am Heart J 156 2008 373.e9-e16
22. M.O. Al Chekakie, J.G. Akar, F. Wang The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation J Cardiovasc Electrophysiol 18 2007 942 946
23. B. Richter, M. Derntl, M. Marx, P. Lercher, H.D. Gossinger Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation Am Heart J 153 2007 113 119
24. P. Bruins, H. te Velthuis, A.P. Yazdanbakhsh Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia Circulation 96 1997 3542 3548
25. S. Kinlay, G.G. Schwartz, A.G. Olsson High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study Circulation 108 2003 1560 1566
26. T. Koyama, H. Tada, Y. Sekiguchi Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation a randomized controlled trial J Am Coll Cardiol 56 2010 1463 1472